Joseph Sessa – Trademark Portfolio
Entity Type: 01
Joseph Sessa holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include BREWNICE, CURVY BEARS, EVIL EYES ONLY, and CURVY BODY BEARS. The owner is based in Hoboken, NJ.
Apt #1
502 Grand St.
Hoboken, NJ 07030
Showing of trademarks Trademarks
Trademark Classifications
Joseph Sessa's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Joseph Sessa have?
Joseph Sessa has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 2 abandoned.
What trademark classes does Joseph Sessa file in?
Joseph Sessa files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 3 (Cosmetics & Cleaning), Class 14 (Jewelry). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Joseph Sessa's most well-known trademarks?
Joseph Sessa's registered trademark portfolio includes well-known marks such as BREWNICE, CURVY BEARS, EVIL EYES ONLY, and CURVY BODY BEARS. These are among 4 currently registered trademarks in the portfolio.
What is Joseph Sessa's trademark registration success rate?
Joseph Sessa has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.